Genetic variations (PNPLA3, TM6SF2, GCKR, MBOAT7, MERTK, and HSD17B13) are one of the non-modifiable risk factors for metabolic dysfunction-associated fatty liver disease (MAFLD) and MASLD [9,14,105,106,107]. Here, GCKR is linked to fatty liver disease.